Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Abicipar pegol—a novel anti-VEGF therapy with a long duration of action
HTML
PDF
Details
Locations
Year:
2019
Type:
editorial
Source:
Eye
DOI:
10.1038/s41433-019-0584-y
Authors:
Elad Moisseiev,
Anat Loewenstein
Institutions:
Tel Aviv University,
Meir Medical Center,
Tel Aviv Sourasky Medical Center
Language:
English
Topic:
Retinal Diseases and Treatments
Subfield:
Ophthalmology
Field:
Medicine
Domain:
Health Sciences
Keywords:
anti-VEGF therapy,
vascular endothelial growth factor,
intravitreal injection,
retinal disease,
neovascular age-related macular degeneration,
diabetic macular edema,
retinal vein occlusion,
duration of drug action
show all 8
SDG:
Good health and well-being
Open Access status:
bronze
OpenAlex ID:
W2973705051
Cites:
4
Cited by:
36
Related to:
9